HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

The widespread use of the integrase strand transfer inhibitor (INSTI) dolutegravir in first-line and second-line antiretroviral therapy (ART) might facilitate emerging resistance. The DTG RESIST study combined data from HIV cohorts to examine patterns of drug resistance mutations (DRMs) and identify...

Celý popis

Podrobná bibliografia

Vydané v:	The lancet HIV Ročník 10; číslo 11; s. e733
Hlavní autori:	Loosli, Tom, Hossmann, Stefanie, Ingle, Suzanne M, Okhai, Hajra, Kusejko, Katharina, Mouton, Johannes, Bellecave, Pantxika, van Sighem, Ard, Stecher, Melanie, d'Arminio Monforte, Antonella, Gill, M John, Sabin, Caroline A, Maartens, Gary, Günthard, Huldrych F, Sterne, Jonathan A C, Lessells, Richard, Egger, Matthias, Kouyos, Roger D
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands 01.11.2023
Predmet:	Cohort Studies Drug Resistance, Viral - genetics Heterocyclic Compounds, 3-Ring - pharmacology Heterocyclic Compounds, 3-Ring - therapeutic use HIV Infections - drug therapy HIV Integrase Inhibitors - pharmacology HIV Integrase Inhibitors - therapeutic use HIV Seropositivity - drug therapy HIV-1 - genetics Humans Lamivudine - therapeutic use Reverse Transcriptase Inhibitors - therapeutic use
ISSN:	2352-3018, 2352-3018
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!